APRE
Aprea Therapeutics, Inc. · Healthcare
Director Marc Duey sold $30K of Aprea Therapeutics, Inc.
Sold$29,583
$4.58Price
6,462Shares
−3%Stake
What APRE did after the filing
- The stock from Fri, Oct 25 close, $4.08
- −12.5%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Dec 9 close.
Traded Fri, Oct 18. Filed Fri, Oct 25, 1:42 PM ET, during the session. Returns use the Oct 25 close and the Dec 9 close. Not investment advice.